MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Sleep-wake Alterations are Associated with a Decreased DTI-ALPS, a Marker of Perivascular Glymphatic Functioning, in Patients with Isolated REM Sleep Behavior Disorder

I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, C. Garcia-Vicente, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, J. Madrir, M. Rol, A. Adan, C. Junqué, A. Iranzo, B. Segura (Barcelona, Spain)

Meeting: 2025 International Congress

Keywords: Magnetic resonance imaging(MRI), Rapid eye movement(REM), Synucleinopathies

Category: Parkinson's disease: Biomarkers (non-Neuroimaging)

Objective: We aimed to explore circadian disruption in iRBD and its association with the Diffusion Tensor Imaging- ALong the Perivascular Space (DTI-ALPS) index, a proxy of perivascular glymphatic dysfunction.

Background: Circadian disturbances have been described in patients with isolated REM sleep behavior disorder (iRBD), a prodromal stage of alpha-synucleinopathies[1,2]. Additionally, actigraphy-measured daytime acceleration, motion time during sleep and their ratio (A/T) have been used to objectively characterize sleep-wake alterations in Parkinson’s Disease[3]. Disturbed circadian rhythmicity has been proposed to impair glymphatic metabolic clearance, potentially contributing to alpha-synuclein accumulation and neurodegeneration[4].

Method: The study sample comprised 42 patients with video-polysomnography-confirmed iRBD recruited from the Sleep Center of the Hospital Clinic de Barcelona, Spain, and 27 healthy controls (HC). All participants underwent clinical examination and wore a circadian monitoring device for 7 days (KronowiseTM). Between-group differences in mean sleep probability, motor acceleration, motion time and the A/T index were analyzed. Actigraphy data were analyzed using repeated measures ANOVAs and FDR-correction for multiple comparisons. Diffusion-weighted imaging data was available for 41 iRBD and 23 HC, for which the DTI-ALPS index was calculated[5]. Correlations were performed between significant circadian metrics and the DTI-ALPS. A threshold of p<.05 was used in all the analyses.

Results: Patients with iRBD exhibited greater non-motor symptomology than HC [table1], lower mean motion time and decreased circadian function index of the motor rhythm [table2], as well as a decreased A/T ratio, reflective of decreased day/night activity contrast [table2b, figure3]. In repeated measures analyses, patients showed increased sleep probability, and decreased motor acceleration and motion time in specific periods of their circadian cycle [figure2). Patients showed a decreased DTI-ALPS index relative to HC, which positively correlated with the A/T index and mean motion time[figure3].

Conclusion: Patients with iRBD exhibit sleep-wake alterations which are associated with decreased perivascular glymphatic diffusivity, suggesting a link between circadian disruptions and impaired glymphatic clearance in early neurodegeneration.

Table 1

Table 1

Table 2

Table 2

Figure 1

Figure 1

Figure 2

Figure 2

Figure 3

Figure 3

References: 1. Winer, J. R. et al. Isolated REM sleep behavior disorder is associated with altered 24-h rest-activity measures. Front. Sleep 2, (2023).

2. Liguori, C. et al. Sleep−wake cycle dysregulation in idiopathic REM sleep behaviour disorder. Journal of Sleep Research 30, 1–6 (2021).

3. Madrid-Navarro, C. J. et al. Multidimensional circadian monitoring by wearable biosensors in Parkinson’s disease. Frontiers in Neurology 9, 1–14 (2018).

4. Buongiorno, M. et al. Altered sleep and neurovascular dysfunction in alpha-synucleinopathies: the perfect storm for glymphatic failure. Frontiers in aging neuroscience, 15 (2023)

5. Martín-Barceló, C.*, et al. DTI-ALPS index: evaluation of several approaches for automatic computation. Congress: ESMRMB (2024). Date: 2-5 October. Barcelona.

To cite this abstract in AMA style:

I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, C. Garcia-Vicente, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, J. Madrir, M. Rol, A. Adan, C. Junqué, A. Iranzo, B. Segura. Sleep-wake Alterations are Associated with a Decreased DTI-ALPS, a Marker of Perivascular Glymphatic Functioning, in Patients with Isolated REM Sleep Behavior Disorder [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/sleep-wake-alterations-are-associated-with-a-decreased-dti-alps-a-marker-of-perivascular-glymphatic-functioning-in-patients-with-isolated-rem-sleep-behavior-disorder/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/sleep-wake-alterations-are-associated-with-a-decreased-dti-alps-a-marker-of-perivascular-glymphatic-functioning-in-patients-with-isolated-rem-sleep-behavior-disorder/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley